DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Feuerstadt P, Hong SJ, Brandt LJ.
Chronic rifaximin use in cirrhotic patients is associated with decreased rate of C. difficile infection.
Dig Dis Sci 2020;
65 (02) 632-638
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.